Sökning: onr:"swepub:oai:research.chalmers.se:2fc4bb0f-1634-4cf8-abae-e6450cc05fbd" >
A meta-analysis of ...
Abstract
Ämnesord
Stäng
- Multiple Outcomes of Raloxifene Evaluation (MORE), a placebo controlled phase III study of raloxifene in postmenopausal osteoporosis, showed that both doses tested (60 mg and 120 mg daily) reduced the risk of vertebral fracture. There was no significant effect on non-vertebral fracture.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
Nyckelord
- epidemiology
- Spinal Fractures
- Placebos
- Humans
- Incidence
- Proportional Hazards Models
- therapeutic use
- Algorithms
- therapeutic use
- epidemiology
- Osteoporotic Fractures
- 80 and over
- drug therapy
- Risk Factors
- Middle Aged
- Treatment Outcome
- Female
- Adult
- Aged
- drug therapy
- Raloxifene
- Aged
- Bone Density Conservation Agents
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
-
Bone
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas